Deep Blue Medical Advances, developer of the T-Line® Hernia Mesh, today announced the close of its Series A1 funding round. This capital will enable Deep Blue Medical to scale up its commercialization and product development efforts to meet rapidly increasing market demand for its T-Line Hernia Mesh.

Deep Blue Medical Advances is developing a portfolio of novel hernia surgery products to address the unacceptably high rate of hernia occurrence and recurrence. Our products enhance hernia surgery with a potentially significant impact on the multi-billion-dollar global hernia device market. Due to its simple yet revolutionary design, the T-Line Hernia Mesh has the potential to reduce hernia occurrence and recurrence by preventing or reducing mesh fixation failure.

Deep Blue Medical Advances Closes Successful Series A1 Funding Round

Deep Blue Medical Advances Closes Successful Series A1 Funding Round

Company Info